Subbu Nambi
Stock Analyst at Guggenheim
(4.93)
# 171
Out of 4,673 analysts
182
Total ratings
74%
Success rate
41.3%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FRNM Freenome | Initiated Coverage: Buy | $21 | $13.81 | +52.06% | 1 | Aug 20, 2026 | |
| NTRA Natera | Reiterated: Buy | $290 → $360 | $332.03 | +8.42% | 8 | Aug 11, 2026 | |
| CYRX Cryoport | Maintained: Buy | $12 → $16 | $17.13 | -6.60% | 5 | Aug 6, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $75 | $79.54 | -5.71% | 12 | Aug 5, 2026 | |
| BRKR Bruker | Maintained: Buy | $70 | $59.56 | +17.53% | 10 | Aug 4, 2026 | |
| WAT Waters | Reiterated: Buy | $440 | $410.70 | +7.13% | 6 | Aug 4, 2026 | |
| TEM Tempus AI | Reiterated: Buy | $65 | $72.69 | -10.58% | 11 | Aug 3, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $65 | $42.31 | +53.63% | 11 | Jul 31, 2026 | |
| GH Guardant Health | Reiterated: Buy | $190 | $170.69 | +11.31% | 17 | Jul 31, 2026 | |
| ILMN Illumina | Reiterated: Buy | $200 → $226 | $219.40 | +3.01% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $11.95 | +0.42% | 8 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $25 | $25.99 | -3.81% | 5 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.9545 | +319.07% | 9 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 → $200 | $218.85 | -8.61% | 8 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $107 | $145.59 | -26.51% | 9 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $74 | $87.07 | -15.01% | 8 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $125 | $95.03 | +31.54% | 6 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.64 | - | 3 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $18.38 | -29.27% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 | $34.20 | +37.43% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $8.65 | -19.08% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $181.13 | - | 6 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.35 | - | 1 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $16.98 | - | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $124.75 | - | 2 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €263.00 | €246.80 | +6.56% | 2 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $26.27 | n/a | 1 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.20 | n/a | 2 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $65.12 | n/a | 2 | Feb 23, 2025 |
Freenome
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $13.81
Upside: +52.06%
Natera
Aug 11, 2026
Reiterated: Buy
Price Target: $290 → $360
Current: $332.03
Upside: +8.42%
Cryoport
Aug 6, 2026
Maintained: Buy
Price Target: $12 → $16
Current: $17.13
Upside: -6.60%
GRAIL
Aug 5, 2026
Reiterated: Buy
Price Target: $75
Current: $79.54
Upside: -5.71%
Bruker
Aug 4, 2026
Maintained: Buy
Price Target: $70
Current: $59.56
Upside: +17.53%
Waters
Aug 4, 2026
Reiterated: Buy
Price Target: $440
Current: $410.70
Upside: +7.13%
Tempus AI
Aug 3, 2026
Reiterated: Buy
Price Target: $65
Current: $72.69
Upside: -10.58%
Veracyte
Jul 31, 2026
Reiterated: Buy
Price Target: $65
Current: $42.31
Upside: +53.63%
Guardant Health
Jul 31, 2026
Reiterated: Buy
Price Target: $190
Current: $170.69
Upside: +11.31%
Illumina
Jul 30, 2026
Reiterated: Buy
Price Target: $200 → $226
Current: $219.40
Upside: +3.01%
Jul 30, 2026
Reiterated: Buy
Price Target: $12
Current: $11.95
Upside: +0.42%
Jul 29, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $25.99
Upside: -3.81%
Jul 28, 2026
Reiterated: Buy
Price Target: $4
Current: $0.9545
Upside: +319.07%
Jul 21, 2026
Reiterated: Buy
Price Target: $235 → $200
Current: $218.85
Upside: -8.61%
Jun 29, 2026
Maintained: Buy
Price Target: $60 → $107
Current: $145.59
Upside: -26.51%
Jun 29, 2026
Maintained: Buy
Price Target: $70 → $74
Current: $87.07
Upside: -15.01%
Jun 29, 2026
Maintained: Buy
Price Target: $120 → $125
Current: $95.03
Upside: +31.54%
May 11, 2026
Maintained: Hold
Price Target: n/a
Current: $8.64
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $13
Current: $18.38
Upside: -29.27%
May 7, 2026
Maintained: Buy
Price Target: $47
Current: $34.20
Upside: +37.43%
May 6, 2026
Reiterated: Buy
Price Target: $7
Current: $8.65
Upside: -19.08%
Feb 24, 2026
Maintained: Hold
Price Target: n/a
Current: $181.13
Upside: -
Feb 12, 2026
Maintained: Hold
Price Target: n/a
Current: $1.35
Upside: -
Oct 28, 2025
Maintained: Hold
Price Target: n/a
Current: $16.98
Upside: -
Oct 27, 2025
Reiterated: Hold
Price Target: n/a
Current: $124.75
Upside: -
Oct 16, 2025
Reiterated: Buy
Price Target: €263.00
Current: €246.80
Upside: +6.56%
Jul 13, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $26.27
Upside: n/a
Apr 8, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.20
Upside: n/a
Feb 23, 2025
Maintained: Hold
Price Target: n/a
Current: $65.12
Upside: n/a